In patients who have undergone transcatheter aortic valve replacement (TAVR), the presence of an imbalance between prosthesis functioning and body size can lessen the positive hemodynamic impact of ...
CHICAGO, IL—Patients undergoing TAVR with a self-expanding supra-annular bioprothesis (CoreValve, Evolut R, or Evolut PRO; Medtronic) have lower aortic valve mean pressure gradients, larger effective ...
SAN DIEGO — Severe prosthesis–patient mismatch (PPM) occurs in more than 10% of patients after transcatheter aortic valve replacement (TAVR) and increases the risk for death but not stroke, according ...
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
In patients undergoing transcatheter aortic valve implantation (TAVI), patient–prosthesis mismatch is associated with increased mortality. Findings from the SMART trial now show that in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results